Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio製藥公司股價上漲，此前HC Wainwright&Co.將該公司股票評級從中性上調至買入，並宣佈了22美元的目標價。
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio製藥公司股價上漲，此前HC Wainwright&Co.將該公司股票評級從中性上調至買入，並宣佈了22美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。